Safest Places to Travel in 2027: Three New Countries and Cities Top Berkshire Hathaway Travel Protection’s Annual Report

Berkshire Hathaway Travel Protection released its 12th annual State of Travel Insurance Safest Destinations report for 2027. Canada, New Zealand and Australia ranked as the safest countries to visit, while Montreal, Zurich and Amsterdam topped the city rankings.

Analysis

The report is a consumer-perception signal, not evidence of booking growth, insurance pricing power, or lower claims. Any benefit to Berkshire Hathaway Travel Protection (BHTP) would depend on travelers converting perceived safety into policy purchases; the article provides no conversion, premium, or underwriting data. Even if BHTP gains share, the impact on Berkshire Hathaway Inc. (BRK.A) cannot be inferred without the subsidiary’s scale and contribution to consolidated results. A possible second-order effect is a modest shift in travel demand toward destinations viewed as safer, but this is too weak to underwrite positions in airlines, hotels, or destination operators.

Near term, expect little fundamental repricing from a survey release. Over 1–3 months, watch whether BHTP or competitors turn safety messaging into measurable policy sales. Over 6–18 months, actual travel volumes, claims experience, and underwriting economics matter more than rankings. The contrarian point is that “safest” perceptions can be fragile and may not track realized travel risk; the ranking should not be treated as a durable demand forecast. No trade is justified absent evidence of material premium growth or a change to Berkshire’s outlook.

Key Decisions for Investors

• No trade in BRK.A on this release; the article does not establish a material consolidated earnings or valuation catalyst.
• Treat any destination-level exposure as a watch item, not a position: look for corroboration in booking data before expressing a view through travel or lodging names.
• Monitor for verifiable BHTP policy-sales or premium growth and any disclosed contribution to Berkshire results; without those data, do not infer market-share gains.
• Reassess only if follow-up evidence shows sustained sales conversion or if subsequent travel and claims data contradict the safety-perception signal.